title: Immunization of elderly people with two doses of influenza vaccine.
abstract: A total of 104 elderly patients were immunized with one or two doses of the commercial 1985-1986 inactivated influenza vaccine formulation. Two types of vaccines (split virus [SV] vaccine and whole virus [WV] vaccine) and one or two doses 1 month apart were given. No difference in local or systemic reactions was noted among the four groups. The reciprocal geometric mean hemagglutination inhibition antibody titers against influenza A/Philippines/82 (H3N2) after one or two doses were: 78 for SV vaccine (one dose), 65 for SV vaccine (two doses), 55 for WV vaccine (one dose), and 51 for WV vaccine (two doses). Similar nonsignificant differences were observed for the other two antigens contained in the vaccine. The percentage with a hemagglutination inhibition titer of greater than or equal to 1:40 also did not differ after one or two doses. We then compared the postvaccination hemagglutination inhibition titers in young and old patients from previous studies in which apparent differences had appeared. We retested all sera simultaneously on the same day with the same reagents. No significant differences were apparent among age groups. In summary, the humoral immune response to inactivated influenza vaccine in healthy ambulatory elderly patients who have been previously immunized may not differ significantly from that of children and young adults. A booster dose 1 month after the first dose does not enhance immune responses in the elderly.
authors: Hackensack Medical Center, New Jersey 07601.
authors: P A
authors: PA
authors: Gross
authors: M E
authors: ME
authors: Weksler
authors: G V
authors: GV
authors: Quinnan
authors: R G
authors: RG
authors: Douglas
authors: P F
authors: PF
authors: Gaerlan
authors: C R
authors: CR
authors: Denning
mesh_terms: D000293:Adolescent; D000368:Aged; D000914:Antibodies, Viral / Q000096:biosynthesis*; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007114:Immunization; D007117:Immunization, Secondary; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology*; D011897:Random Allocation
chemical_list: D000914:Antibodies, Viral; D007252:Influenza Vaccines